Search Results

There are 7760999 results for: content related to: Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major

  1. You have free access to this content
    Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients

    British Journal of Haematology

    Volume 98, Issue 4, September 1997, Pages: 850–855, P. T. Telfer, J. A. Garson, K. Whitby, P. R. Grant, A. Yardumian, A. V. Hoffbrand and B. Wonke

    Version of Record online : 14 NOV 2003, DOI: 10.1046/j.1365-2141.1997.2953112.x

  2. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  3. Pharmacokinetics and Safety of Viramidine, a Prodrug of Ribavirin, in Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 44, Issue 3, March 2004, Pages: 265–275, Chin-Chung Lin, Lee Philips, Christine Xu and Li-Tain Yeh

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004262974

  4. Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis

    Journal of Viral Hepatitis

    Volume 17, Issue 4, April 2010, Pages: 236–244, S.-M. Alavian and S.-V. Tabatabaei

    Version of Record online : 23 JUL 2009, DOI: 10.1111/j.1365-2893.2009.01170.x

  5. You have free access to this content
    Diagnosis, management, and treatment of hepatitis C: An update

    Hepatology

    Volume 49, Issue 4, April 2009, Pages: 1335–1374, Marc G. Ghany, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 2 DEC 2008, DOI: 10.1002/hep.22759

  6. You have free access to this content
    Synthesis and Evaluation of Bile Acid–Ribavirin Conjugates as Prodrugs to Target the Liver

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 9, September 2015, Pages: 2864–2876, Zhongqi Dong, Qing Li, Dong Guo, Yan Shu and James E. Polli

    Version of Record online : 2 FEB 2015, DOI: 10.1002/jps.24375

  7. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  8. Treatment of Chronic Hepatitis C

    Viral Hepatitis, Third Edition

    Jenny Heathcote, Janice Main, Pages: 526–539, 2007

    Published Online : 26 OCT 2007, DOI: 10.1002/9780470987131.ch33

  9. You have free access to this content
    Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters

    British Journal of Pharmacology

    Volume 123, Issue 8, April 1998, Pages: 1587–1592, Simon M. Jarvis, James A. Thorn and Paul Glue

    Version of Record online : 10 FEB 2009, DOI: 10.1038/sj.bjp.0701775

  10. Ribavirin monotherapy for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Jesper Brok, Lise Lotte Gluud and Christian Gluud

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD005527.pub2

  11. You have free access to this content
    Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon α-2b and ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1346–1353, A. MANGIA, O. DALGARD, N. MINERVA, H. VERBAAN, D. BACCA, H. RING-LARSEN, M. COPETTI, V. CARRETTA, V. PIAZZOLLA, R. COZZOLONGO, L. MOTTOLA and A. ANDRIULLI

    Version of Record online : 8 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04290.x

  12. Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection

    Journal of Viral Hepatitis

    Volume 18, Issue 4, April 2011, Pages: 245–251, C. Pedersen, Å. Alsiö, M. Lagging, N. Langeland, M. Färkkilä, M. Rauning Buhl, K. Mørch, J. Westin, P. Sangfelt, G. Norkrans, P. Brehm Christensen and for the NORDynamicIC Study Group

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1365-2893.2010.01303.x

  13. You have free access to this content
    Hepatitis C virus: How genetic variability affects pathobiology of disease

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue s1, January 2011, Pages: 83–95, Kazuaki Chayama and C Nelson Hayes

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1440-1746.2010.06550.x

  14. You have free access to this content
    Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

    British Journal of Clinical Pharmacology

    Volume 46, Issue 6, December 1998, Pages: 563–570, Salim Khakoo, Paul Glue, Leonie Grellier, Beverley Wells, Allan Bell, Clive Dash, Iain Murray-Lyon, David Lypnyj, Brian Flannery, Karen Walters and Geoffrey M Dusheiko

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2125.1998.00836.x

  15. You have free access to this content
    Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Goran Hauser, Tahany Awad, Jesper Brok, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud and Lise Lotte Gluud

    Published Online : 28 FEB 2014, DOI: 10.1002/14651858.CD005441.pub3

  16. Ribavirin in the treatment of chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 6, June 2008, Pages: 844–855, Paul Martin and Donald M Jensen

    Version of Record online : 6 JUN 2008, DOI: 10.1111/j.1440-1746.2008.05398.x

  17. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  18. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  19. Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads

    Hepatology Research

    Volume 41, Issue 7, July 2011, Pages: 626–634, Hiroshi Kohno, Hirotaka Kouno, Shiomi Aimitsu, Yasuyuki Aisaka, Mikiya Kitamoto, Hiroiku Kawakami and Kazuaki Chayama

    Version of Record online : 28 JUN 2011, DOI: 10.1111/j.1872-034X.2011.00811.x

  20. You have free access to this content
    AASLD Abstract (pp. 162A–266A)

    Hepatology

    Volume 40, Issue S4, October 2004, Pages: 267A–369A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840400504